Global Plasma-derived Factor VIII Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Plasma-derived Factor VIII market size was valued at US$ 8570.4 million in 2023. With growing demand in downstream market, the Plasma-derived Factor VIII is forecast to a readjusted size of US$ 12810 million by 2030 with a CAGR of 5.9% during review period.
The research report highlights the growth potential of the global Plasma-derived Factor VIII market. Plasma-derived Factor VIII are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Plasma-derived Factor VIII. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Plasma-derived Factor VIII market.
RECOMBINATE is recombinant Factor VIII, a clotting factor that is deficient in people with hemophilia A.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of hemophilia A and the rising awareness about the importance of early diagnosis and treatment have led to a growing demand for Factor VIII products. The availability of plasma-derived Factor VIII provides an effective treatment option for patients who require clotting factor replacement therapy. Secondly, advancements in manufacturing techniques and purification processes have improved the safety and efficacy of plasma-derived Factor VIII products. Stringent regulatory standards and guidelines for plasma collection and fractionation have instilled confidence among healthcare providers and patients regarding the safety of these products.
Key Features:
The report on Plasma-derived Factor VIII market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Plasma-derived Factor VIII market. It may include historical data, market segmentation by Type (e.g., 200IU, 250IU), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Plasma-derived Factor VIII market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Plasma-derived Factor VIII market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Plasma-derived Factor VIII industry. This include advancements in Plasma-derived Factor VIII technology, Plasma-derived Factor VIII new entrants, Plasma-derived Factor VIII new investment, and other innovations that are shaping the future of Plasma-derived Factor VIII.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Plasma-derived Factor VIII market. It includes factors influencing customer ' purchasing decisions, preferences for Plasma-derived Factor VIII product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Plasma-derived Factor VIII market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Plasma-derived Factor VIII market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Plasma-derived Factor VIII market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Plasma-derived Factor VIII industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Plasma-derived Factor VIII market.
Market Segmentation:
Plasma-derived Factor VIII market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Plasma-derived Factor VIII market?
What factors are driving Plasma-derived Factor VIII market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plasma-derived Factor VIII market opportunities vary by end market size?
How does Plasma-derived Factor VIII break out type, application?
According to our LPI (LP Information) latest study, the global Plasma-derived Factor VIII market size was valued at US$ 8570.4 million in 2023. With growing demand in downstream market, the Plasma-derived Factor VIII is forecast to a readjusted size of US$ 12810 million by 2030 with a CAGR of 5.9% during review period.
The research report highlights the growth potential of the global Plasma-derived Factor VIII market. Plasma-derived Factor VIII are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Plasma-derived Factor VIII. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Plasma-derived Factor VIII market.
RECOMBINATE is recombinant Factor VIII, a clotting factor that is deficient in people with hemophilia A.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of hemophilia A and the rising awareness about the importance of early diagnosis and treatment have led to a growing demand for Factor VIII products. The availability of plasma-derived Factor VIII provides an effective treatment option for patients who require clotting factor replacement therapy. Secondly, advancements in manufacturing techniques and purification processes have improved the safety and efficacy of plasma-derived Factor VIII products. Stringent regulatory standards and guidelines for plasma collection and fractionation have instilled confidence among healthcare providers and patients regarding the safety of these products.
Key Features:
The report on Plasma-derived Factor VIII market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Plasma-derived Factor VIII market. It may include historical data, market segmentation by Type (e.g., 200IU, 250IU), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Plasma-derived Factor VIII market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Plasma-derived Factor VIII market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Plasma-derived Factor VIII industry. This include advancements in Plasma-derived Factor VIII technology, Plasma-derived Factor VIII new entrants, Plasma-derived Factor VIII new investment, and other innovations that are shaping the future of Plasma-derived Factor VIII.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Plasma-derived Factor VIII market. It includes factors influencing customer ' purchasing decisions, preferences for Plasma-derived Factor VIII product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Plasma-derived Factor VIII market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Plasma-derived Factor VIII market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Plasma-derived Factor VIII market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Plasma-derived Factor VIII industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Plasma-derived Factor VIII market.
Market Segmentation:
Plasma-derived Factor VIII market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- 200IU
- 250IU
- Hospital
- Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda
- Octapharma
- CSL
- Grifols
- Greencross
- Kedrion
- BPL
- Hualan Bio
- RAAS
What is the 10-year outlook for the global Plasma-derived Factor VIII market?
What factors are driving Plasma-derived Factor VIII market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plasma-derived Factor VIII market opportunities vary by end market size?
How does Plasma-derived Factor VIII break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Plasma-derived Factor VIII Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Plasma-derived Factor VIII by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Plasma-derived Factor VIII by Country/Region, 2019, 2023 & 2030
2.2 Plasma-derived Factor VIII Segment by Type
2.2.1 200IU
2.2.2 250IU
2.3 Plasma-derived Factor VIII Sales by Type
2.3.1 Global Plasma-derived Factor VIII Sales Market Share by Type (2019-2024)
2.3.2 Global Plasma-derived Factor VIII Revenue and Market Share by Type (2019-2024)
2.3.3 Global Plasma-derived Factor VIII Sale Price by Type (2019-2024)
2.4 Plasma-derived Factor VIII Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Plasma-derived Factor VIII Sales by Application
2.5.1 Global Plasma-derived Factor VIII Sale Market Share by Application (2019-2024)
2.5.2 Global Plasma-derived Factor VIII Revenue and Market Share by Application (2019-2024)
2.5.3 Global Plasma-derived Factor VIII Sale Price by Application (2019-2024)
3 GLOBAL PLASMA-DERIVED FACTOR VIII BY COMPANY
3.1 Global Plasma-derived Factor VIII Breakdown Data by Company
3.1.1 Global Plasma-derived Factor VIII Annual Sales by Company (2019-2024)
3.1.2 Global Plasma-derived Factor VIII Sales Market Share by Company (2019-2024)
3.2 Global Plasma-derived Factor VIII Annual Revenue by Company (2019-2024)
3.2.1 Global Plasma-derived Factor VIII Revenue by Company (2019-2024)
3.2.2 Global Plasma-derived Factor VIII Revenue Market Share by Company (2019-2024)
3.3 Global Plasma-derived Factor VIII Sale Price by Company
3.4 Key Manufacturers Plasma-derived Factor VIII Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma-derived Factor VIII Product Location Distribution
3.4.2 Players Plasma-derived Factor VIII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PLASMA-DERIVED FACTOR VIII BY GEOGRAPHIC REGION
4.1 World Historic Plasma-derived Factor VIII Market Size by Geographic Region (2019-2024)
4.1.1 Global Plasma-derived Factor VIII Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Plasma-derived Factor VIII Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Plasma-derived Factor VIII Market Size by Country/Region (2019-2024)
4.2.1 Global Plasma-derived Factor VIII Annual Sales by Country/Region (2019-2024)
4.2.2 Global Plasma-derived Factor VIII Annual Revenue by Country/Region (2019-2024)
4.3 Americas Plasma-derived Factor VIII Sales Growth
4.4 APAC Plasma-derived Factor VIII Sales Growth
4.5 Europe Plasma-derived Factor VIII Sales Growth
4.6 Middle East & Africa Plasma-derived Factor VIII Sales Growth
5 AMERICAS
5.1 Americas Plasma-derived Factor VIII Sales by Country
5.1.1 Americas Plasma-derived Factor VIII Sales by Country (2019-2024)
5.1.2 Americas Plasma-derived Factor VIII Revenue by Country (2019-2024)
5.2 Americas Plasma-derived Factor VIII Sales by Type
5.3 Americas Plasma-derived Factor VIII Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma-derived Factor VIII Sales by Region
6.1.1 APAC Plasma-derived Factor VIII Sales by Region (2019-2024)
6.1.2 APAC Plasma-derived Factor VIII Revenue by Region (2019-2024)
6.2 APAC Plasma-derived Factor VIII Sales by Type
6.3 APAC Plasma-derived Factor VIII Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Plasma-derived Factor VIII by Country
7.1.1 Europe Plasma-derived Factor VIII Sales by Country (2019-2024)
7.1.2 Europe Plasma-derived Factor VIII Revenue by Country (2019-2024)
7.2 Europe Plasma-derived Factor VIII Sales by Type
7.3 Europe Plasma-derived Factor VIII Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Plasma-derived Factor VIII by Country
8.1.1 Middle East & Africa Plasma-derived Factor VIII Sales by Country (2019-2024)
8.1.2 Middle East & Africa Plasma-derived Factor VIII Revenue by Country (2019-2024)
8.2 Middle East & Africa Plasma-derived Factor VIII Sales by Type
8.3 Middle East & Africa Plasma-derived Factor VIII Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plasma-derived Factor VIII
10.3 Manufacturing Process Analysis of Plasma-derived Factor VIII
10.4 Industry Chain Structure of Plasma-derived Factor VIII
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plasma-derived Factor VIII Distributors
11.3 Plasma-derived Factor VIII Customer
12 WORLD FORECAST REVIEW FOR PLASMA-DERIVED FACTOR VIII BY GEOGRAPHIC REGION
12.1 Global Plasma-derived Factor VIII Market Size Forecast by Region
12.1.1 Global Plasma-derived Factor VIII Forecast by Region (2025-2030)
12.1.2 Global Plasma-derived Factor VIII Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Plasma-derived Factor VIII Forecast by Type
12.7 Global Plasma-derived Factor VIII Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Plasma-derived Factor VIII Product Portfolios and Specifications
13.1.3 Takeda Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Octapharma
13.2.1 Octapharma Company Information
13.2.2 Octapharma Plasma-derived Factor VIII Product Portfolios and Specifications
13.2.3 Octapharma Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Octapharma Main Business Overview
13.2.5 Octapharma Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Plasma-derived Factor VIII Product Portfolios and Specifications
13.3.3 CSL Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Plasma-derived Factor VIII Product Portfolios and Specifications
13.4.3 Grifols Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 Greencross
13.5.1 Greencross Company Information
13.5.2 Greencross Plasma-derived Factor VIII Product Portfolios and Specifications
13.5.3 Greencross Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Greencross Main Business Overview
13.5.5 Greencross Latest Developments
13.6 Kedrion
13.6.1 Kedrion Company Information
13.6.2 Kedrion Plasma-derived Factor VIII Product Portfolios and Specifications
13.6.3 Kedrion Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Kedrion Main Business Overview
13.6.5 Kedrion Latest Developments
13.7 BPL
13.7.1 BPL Company Information
13.7.2 BPL Plasma-derived Factor VIII Product Portfolios and Specifications
13.7.3 BPL Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 BPL Main Business Overview
13.7.5 BPL Latest Developments
13.8 Hualan Bio
13.8.1 Hualan Bio Company Information
13.8.2 Hualan Bio Plasma-derived Factor VIII Product Portfolios and Specifications
13.8.3 Hualan Bio Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hualan Bio Main Business Overview
13.8.5 Hualan Bio Latest Developments
13.9 RAAS
13.9.1 RAAS Company Information
13.9.2 RAAS Plasma-derived Factor VIII Product Portfolios and Specifications
13.9.3 RAAS Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 RAAS Main Business Overview
13.9.5 RAAS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Plasma-derived Factor VIII Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Plasma-derived Factor VIII by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Plasma-derived Factor VIII by Country/Region, 2019, 2023 & 2030
2.2 Plasma-derived Factor VIII Segment by Type
2.2.1 200IU
2.2.2 250IU
2.3 Plasma-derived Factor VIII Sales by Type
2.3.1 Global Plasma-derived Factor VIII Sales Market Share by Type (2019-2024)
2.3.2 Global Plasma-derived Factor VIII Revenue and Market Share by Type (2019-2024)
2.3.3 Global Plasma-derived Factor VIII Sale Price by Type (2019-2024)
2.4 Plasma-derived Factor VIII Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Plasma-derived Factor VIII Sales by Application
2.5.1 Global Plasma-derived Factor VIII Sale Market Share by Application (2019-2024)
2.5.2 Global Plasma-derived Factor VIII Revenue and Market Share by Application (2019-2024)
2.5.3 Global Plasma-derived Factor VIII Sale Price by Application (2019-2024)
3 GLOBAL PLASMA-DERIVED FACTOR VIII BY COMPANY
3.1 Global Plasma-derived Factor VIII Breakdown Data by Company
3.1.1 Global Plasma-derived Factor VIII Annual Sales by Company (2019-2024)
3.1.2 Global Plasma-derived Factor VIII Sales Market Share by Company (2019-2024)
3.2 Global Plasma-derived Factor VIII Annual Revenue by Company (2019-2024)
3.2.1 Global Plasma-derived Factor VIII Revenue by Company (2019-2024)
3.2.2 Global Plasma-derived Factor VIII Revenue Market Share by Company (2019-2024)
3.3 Global Plasma-derived Factor VIII Sale Price by Company
3.4 Key Manufacturers Plasma-derived Factor VIII Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma-derived Factor VIII Product Location Distribution
3.4.2 Players Plasma-derived Factor VIII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PLASMA-DERIVED FACTOR VIII BY GEOGRAPHIC REGION
4.1 World Historic Plasma-derived Factor VIII Market Size by Geographic Region (2019-2024)
4.1.1 Global Plasma-derived Factor VIII Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Plasma-derived Factor VIII Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Plasma-derived Factor VIII Market Size by Country/Region (2019-2024)
4.2.1 Global Plasma-derived Factor VIII Annual Sales by Country/Region (2019-2024)
4.2.2 Global Plasma-derived Factor VIII Annual Revenue by Country/Region (2019-2024)
4.3 Americas Plasma-derived Factor VIII Sales Growth
4.4 APAC Plasma-derived Factor VIII Sales Growth
4.5 Europe Plasma-derived Factor VIII Sales Growth
4.6 Middle East & Africa Plasma-derived Factor VIII Sales Growth
5 AMERICAS
5.1 Americas Plasma-derived Factor VIII Sales by Country
5.1.1 Americas Plasma-derived Factor VIII Sales by Country (2019-2024)
5.1.2 Americas Plasma-derived Factor VIII Revenue by Country (2019-2024)
5.2 Americas Plasma-derived Factor VIII Sales by Type
5.3 Americas Plasma-derived Factor VIII Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma-derived Factor VIII Sales by Region
6.1.1 APAC Plasma-derived Factor VIII Sales by Region (2019-2024)
6.1.2 APAC Plasma-derived Factor VIII Revenue by Region (2019-2024)
6.2 APAC Plasma-derived Factor VIII Sales by Type
6.3 APAC Plasma-derived Factor VIII Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Plasma-derived Factor VIII by Country
7.1.1 Europe Plasma-derived Factor VIII Sales by Country (2019-2024)
7.1.2 Europe Plasma-derived Factor VIII Revenue by Country (2019-2024)
7.2 Europe Plasma-derived Factor VIII Sales by Type
7.3 Europe Plasma-derived Factor VIII Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Plasma-derived Factor VIII by Country
8.1.1 Middle East & Africa Plasma-derived Factor VIII Sales by Country (2019-2024)
8.1.2 Middle East & Africa Plasma-derived Factor VIII Revenue by Country (2019-2024)
8.2 Middle East & Africa Plasma-derived Factor VIII Sales by Type
8.3 Middle East & Africa Plasma-derived Factor VIII Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plasma-derived Factor VIII
10.3 Manufacturing Process Analysis of Plasma-derived Factor VIII
10.4 Industry Chain Structure of Plasma-derived Factor VIII
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plasma-derived Factor VIII Distributors
11.3 Plasma-derived Factor VIII Customer
12 WORLD FORECAST REVIEW FOR PLASMA-DERIVED FACTOR VIII BY GEOGRAPHIC REGION
12.1 Global Plasma-derived Factor VIII Market Size Forecast by Region
12.1.1 Global Plasma-derived Factor VIII Forecast by Region (2025-2030)
12.1.2 Global Plasma-derived Factor VIII Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Plasma-derived Factor VIII Forecast by Type
12.7 Global Plasma-derived Factor VIII Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Plasma-derived Factor VIII Product Portfolios and Specifications
13.1.3 Takeda Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Octapharma
13.2.1 Octapharma Company Information
13.2.2 Octapharma Plasma-derived Factor VIII Product Portfolios and Specifications
13.2.3 Octapharma Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Octapharma Main Business Overview
13.2.5 Octapharma Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Plasma-derived Factor VIII Product Portfolios and Specifications
13.3.3 CSL Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Plasma-derived Factor VIII Product Portfolios and Specifications
13.4.3 Grifols Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 Greencross
13.5.1 Greencross Company Information
13.5.2 Greencross Plasma-derived Factor VIII Product Portfolios and Specifications
13.5.3 Greencross Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Greencross Main Business Overview
13.5.5 Greencross Latest Developments
13.6 Kedrion
13.6.1 Kedrion Company Information
13.6.2 Kedrion Plasma-derived Factor VIII Product Portfolios and Specifications
13.6.3 Kedrion Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Kedrion Main Business Overview
13.6.5 Kedrion Latest Developments
13.7 BPL
13.7.1 BPL Company Information
13.7.2 BPL Plasma-derived Factor VIII Product Portfolios and Specifications
13.7.3 BPL Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 BPL Main Business Overview
13.7.5 BPL Latest Developments
13.8 Hualan Bio
13.8.1 Hualan Bio Company Information
13.8.2 Hualan Bio Plasma-derived Factor VIII Product Portfolios and Specifications
13.8.3 Hualan Bio Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hualan Bio Main Business Overview
13.8.5 Hualan Bio Latest Developments
13.9 RAAS
13.9.1 RAAS Company Information
13.9.2 RAAS Plasma-derived Factor VIII Product Portfolios and Specifications
13.9.3 RAAS Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 RAAS Main Business Overview
13.9.5 RAAS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Plasma-derived Factor VIII Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Plasma-derived Factor VIII Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 200IU
Table 4. Major Players of 250IU
Table 5. Global Plasma-derived Factor VIII Sales by Type (2019-2024) & (K Units)
Table 6. Global Plasma-derived Factor VIII Sales Market Share by Type (2019-2024)
Table 7. Global Plasma-derived Factor VIII Revenue by Type (2019-2024) & ($ million)
Table 8. Global Plasma-derived Factor VIII Revenue Market Share by Type (2019-2024)
Table 9. Global Plasma-derived Factor VIII Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Plasma-derived Factor VIII Sales by Application (2019-2024) & (K Units)
Table 11. Global Plasma-derived Factor VIII Sales Market Share by Application (2019-2024)
Table 12. Global Plasma-derived Factor VIII Revenue by Application (2019-2024)
Table 13. Global Plasma-derived Factor VIII Revenue Market Share by Application (2019-2024)
Table 14. Global Plasma-derived Factor VIII Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Plasma-derived Factor VIII Sales by Company (2019-2024) & (K Units)
Table 16. Global Plasma-derived Factor VIII Sales Market Share by Company (2019-2024)
Table 17. Global Plasma-derived Factor VIII Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Plasma-derived Factor VIII Revenue Market Share by Company (2019-2024)
Table 19. Global Plasma-derived Factor VIII Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Plasma-derived Factor VIII Producing Area Distribution and Sales Area
Table 21. Players Plasma-derived Factor VIII Products Offered
Table 22. Plasma-derived Factor VIII Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Plasma-derived Factor VIII Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Plasma-derived Factor VIII Sales Market Share Geographic Region (2019-2024)
Table 27. Global Plasma-derived Factor VIII Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Plasma-derived Factor VIII Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Plasma-derived Factor VIII Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Plasma-derived Factor VIII Sales Market Share by Country/Region (2019-2024)
Table 31. Global Plasma-derived Factor VIII Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Plasma-derived Factor VIII Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Plasma-derived Factor VIII Sales by Country (2019-2024) & (K Units)
Table 34. Americas Plasma-derived Factor VIII Sales Market Share by Country (2019-2024)
Table 35. Americas Plasma-derived Factor VIII Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Plasma-derived Factor VIII Revenue Market Share by Country (2019-2024)
Table 37. Americas Plasma-derived Factor VIII Sales by Type (2019-2024) & (K Units)
Table 38. Americas Plasma-derived Factor VIII Sales by Application (2019-2024) & (K Units)
Table 39. APAC Plasma-derived Factor VIII Sales by Region (2019-2024) & (K Units)
Table 40. APAC Plasma-derived Factor VIII Sales Market Share by Region (2019-2024)
Table 41. APAC Plasma-derived Factor VIII Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Plasma-derived Factor VIII Revenue Market Share by Region (2019-2024)
Table 43. APAC Plasma-derived Factor VIII Sales by Type (2019-2024) & (K Units)
Table 44. APAC Plasma-derived Factor VIII Sales by Application (2019-2024) & (K Units)
Table 45. Europe Plasma-derived Factor VIII Sales by Country (2019-2024) & (K Units)
Table 46. Europe Plasma-derived Factor VIII Sales Market Share by Country (2019-2024)
Table 47. Europe Plasma-derived Factor VIII Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Plasma-derived Factor VIII Revenue Market Share by Country (2019-2024)
Table 49. Europe Plasma-derived Factor VIII Sales by Type (2019-2024) & (K Units)
Table 50. Europe Plasma-derived Factor VIII Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Plasma-derived Factor VIII Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Plasma-derived Factor VIII Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Plasma-derived Factor VIII Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Plasma-derived Factor VIII Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Plasma-derived Factor VIII Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Plasma-derived Factor VIII
Table 58. Key Market Challenges & Risks of Plasma-derived Factor VIII
Table 59. Key Industry Trends of Plasma-derived Factor VIII
Table 60. Plasma-derived Factor VIII Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Plasma-derived Factor VIII Distributors List
Table 63. Plasma-derived Factor VIII Customer List
Table 64. Global Plasma-derived Factor VIII Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Plasma-derived Factor VIII Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Plasma-derived Factor VIII Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Plasma-derived Factor VIII Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Plasma-derived Factor VIII Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Plasma-derived Factor VIII Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Plasma-derived Factor VIII Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Plasma-derived Factor VIII Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Plasma-derived Factor VIII Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Plasma-derived Factor VIII Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Plasma-derived Factor VIII Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Plasma-derived Factor VIII Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Plasma-derived Factor VIII Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Plasma-derived Factor VIII Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Takeda Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 79. Takeda Plasma-derived Factor VIII Product Portfolios and Specifications
Table 80. Takeda Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Takeda Main Business
Table 82. Takeda Latest Developments
Table 83. Octapharma Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 84. Octapharma Plasma-derived Factor VIII Product Portfolios and Specifications
Table 85. Octapharma Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Octapharma Main Business
Table 87. Octapharma Latest Developments
Table 88. CSL Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 89. CSL Plasma-derived Factor VIII Product Portfolios and Specifications
Table 90. CSL Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. CSL Main Business
Table 92. CSL Latest Developments
Table 93. Grifols Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 94. Grifols Plasma-derived Factor VIII Product Portfolios and Specifications
Table 95. Grifols Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Grifols Main Business
Table 97. Grifols Latest Developments
Table 98. Greencross Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 99. Greencross Plasma-derived Factor VIII Product Portfolios and Specifications
Table 100. Greencross Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Greencross Main Business
Table 102. Greencross Latest Developments
Table 103. Kedrion Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 104. Kedrion Plasma-derived Factor VIII Product Portfolios and Specifications
Table 105. Kedrion Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Kedrion Main Business
Table 107. Kedrion Latest Developments
Table 108. BPL Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 109. BPL Plasma-derived Factor VIII Product Portfolios and Specifications
Table 110. BPL Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. BPL Main Business
Table 112. BPL Latest Developments
Table 113. Hualan Bio Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 114. Hualan Bio Plasma-derived Factor VIII Product Portfolios and Specifications
Table 115. Hualan Bio Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Hualan Bio Main Business
Table 117. Hualan Bio Latest Developments
Table 118. RAAS Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 119. RAAS Plasma-derived Factor VIII Product Portfolios and Specifications
Table 120. RAAS Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. RAAS Main Business
Table 122. RAAS Latest Developments
Table 1. Plasma-derived Factor VIII Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Plasma-derived Factor VIII Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 200IU
Table 4. Major Players of 250IU
Table 5. Global Plasma-derived Factor VIII Sales by Type (2019-2024) & (K Units)
Table 6. Global Plasma-derived Factor VIII Sales Market Share by Type (2019-2024)
Table 7. Global Plasma-derived Factor VIII Revenue by Type (2019-2024) & ($ million)
Table 8. Global Plasma-derived Factor VIII Revenue Market Share by Type (2019-2024)
Table 9. Global Plasma-derived Factor VIII Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Plasma-derived Factor VIII Sales by Application (2019-2024) & (K Units)
Table 11. Global Plasma-derived Factor VIII Sales Market Share by Application (2019-2024)
Table 12. Global Plasma-derived Factor VIII Revenue by Application (2019-2024)
Table 13. Global Plasma-derived Factor VIII Revenue Market Share by Application (2019-2024)
Table 14. Global Plasma-derived Factor VIII Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Plasma-derived Factor VIII Sales by Company (2019-2024) & (K Units)
Table 16. Global Plasma-derived Factor VIII Sales Market Share by Company (2019-2024)
Table 17. Global Plasma-derived Factor VIII Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Plasma-derived Factor VIII Revenue Market Share by Company (2019-2024)
Table 19. Global Plasma-derived Factor VIII Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Plasma-derived Factor VIII Producing Area Distribution and Sales Area
Table 21. Players Plasma-derived Factor VIII Products Offered
Table 22. Plasma-derived Factor VIII Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Plasma-derived Factor VIII Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Plasma-derived Factor VIII Sales Market Share Geographic Region (2019-2024)
Table 27. Global Plasma-derived Factor VIII Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Plasma-derived Factor VIII Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Plasma-derived Factor VIII Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Plasma-derived Factor VIII Sales Market Share by Country/Region (2019-2024)
Table 31. Global Plasma-derived Factor VIII Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Plasma-derived Factor VIII Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Plasma-derived Factor VIII Sales by Country (2019-2024) & (K Units)
Table 34. Americas Plasma-derived Factor VIII Sales Market Share by Country (2019-2024)
Table 35. Americas Plasma-derived Factor VIII Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Plasma-derived Factor VIII Revenue Market Share by Country (2019-2024)
Table 37. Americas Plasma-derived Factor VIII Sales by Type (2019-2024) & (K Units)
Table 38. Americas Plasma-derived Factor VIII Sales by Application (2019-2024) & (K Units)
Table 39. APAC Plasma-derived Factor VIII Sales by Region (2019-2024) & (K Units)
Table 40. APAC Plasma-derived Factor VIII Sales Market Share by Region (2019-2024)
Table 41. APAC Plasma-derived Factor VIII Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Plasma-derived Factor VIII Revenue Market Share by Region (2019-2024)
Table 43. APAC Plasma-derived Factor VIII Sales by Type (2019-2024) & (K Units)
Table 44. APAC Plasma-derived Factor VIII Sales by Application (2019-2024) & (K Units)
Table 45. Europe Plasma-derived Factor VIII Sales by Country (2019-2024) & (K Units)
Table 46. Europe Plasma-derived Factor VIII Sales Market Share by Country (2019-2024)
Table 47. Europe Plasma-derived Factor VIII Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Plasma-derived Factor VIII Revenue Market Share by Country (2019-2024)
Table 49. Europe Plasma-derived Factor VIII Sales by Type (2019-2024) & (K Units)
Table 50. Europe Plasma-derived Factor VIII Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Plasma-derived Factor VIII Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Plasma-derived Factor VIII Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Plasma-derived Factor VIII Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Plasma-derived Factor VIII Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Plasma-derived Factor VIII Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Plasma-derived Factor VIII
Table 58. Key Market Challenges & Risks of Plasma-derived Factor VIII
Table 59. Key Industry Trends of Plasma-derived Factor VIII
Table 60. Plasma-derived Factor VIII Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Plasma-derived Factor VIII Distributors List
Table 63. Plasma-derived Factor VIII Customer List
Table 64. Global Plasma-derived Factor VIII Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Plasma-derived Factor VIII Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Plasma-derived Factor VIII Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Plasma-derived Factor VIII Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Plasma-derived Factor VIII Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Plasma-derived Factor VIII Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Plasma-derived Factor VIII Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Plasma-derived Factor VIII Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Plasma-derived Factor VIII Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Plasma-derived Factor VIII Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Plasma-derived Factor VIII Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Plasma-derived Factor VIII Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Plasma-derived Factor VIII Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Plasma-derived Factor VIII Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Takeda Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 79. Takeda Plasma-derived Factor VIII Product Portfolios and Specifications
Table 80. Takeda Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Takeda Main Business
Table 82. Takeda Latest Developments
Table 83. Octapharma Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 84. Octapharma Plasma-derived Factor VIII Product Portfolios and Specifications
Table 85. Octapharma Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Octapharma Main Business
Table 87. Octapharma Latest Developments
Table 88. CSL Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 89. CSL Plasma-derived Factor VIII Product Portfolios and Specifications
Table 90. CSL Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. CSL Main Business
Table 92. CSL Latest Developments
Table 93. Grifols Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 94. Grifols Plasma-derived Factor VIII Product Portfolios and Specifications
Table 95. Grifols Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Grifols Main Business
Table 97. Grifols Latest Developments
Table 98. Greencross Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 99. Greencross Plasma-derived Factor VIII Product Portfolios and Specifications
Table 100. Greencross Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Greencross Main Business
Table 102. Greencross Latest Developments
Table 103. Kedrion Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 104. Kedrion Plasma-derived Factor VIII Product Portfolios and Specifications
Table 105. Kedrion Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Kedrion Main Business
Table 107. Kedrion Latest Developments
Table 108. BPL Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 109. BPL Plasma-derived Factor VIII Product Portfolios and Specifications
Table 110. BPL Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. BPL Main Business
Table 112. BPL Latest Developments
Table 113. Hualan Bio Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 114. Hualan Bio Plasma-derived Factor VIII Product Portfolios and Specifications
Table 115. Hualan Bio Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Hualan Bio Main Business
Table 117. Hualan Bio Latest Developments
Table 118. RAAS Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 119. RAAS Plasma-derived Factor VIII Product Portfolios and Specifications
Table 120. RAAS Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. RAAS Main Business
Table 122. RAAS Latest Developments
LIST OF FIGURES
Figure 1. Picture of Plasma-derived Factor VIII
Figure 2. Plasma-derived Factor VIII Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma-derived Factor VIII Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Plasma-derived Factor VIII Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Plasma-derived Factor VIII Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 200IU
Figure 10. Product Picture of 250IU
Figure 11. Global Plasma-derived Factor VIII Sales Market Share by Type in 2023
Figure 12. Global Plasma-derived Factor VIII Revenue Market Share by Type (2019-2024)
Figure 13. Plasma-derived Factor VIII Consumed in Hospital
Figure 14. Global Plasma-derived Factor VIII Market: Hospital (2019-2024) & (K Units)
Figure 15. Plasma-derived Factor VIII Consumed in Pharmacy
Figure 16. Global Plasma-derived Factor VIII Market: Pharmacy (2019-2024) & (K Units)
Figure 17. Global Plasma-derived Factor VIII Sales Market Share by Application (2023)
Figure 18. Global Plasma-derived Factor VIII Revenue Market Share by Application in 2023
Figure 19. Plasma-derived Factor VIII Sales Market by Company in 2023 (K Units)
Figure 20. Global Plasma-derived Factor VIII Sales Market Share by Company in 2023
Figure 21. Plasma-derived Factor VIII Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Plasma-derived Factor VIII Revenue Market Share by Company in 2023
Figure 23. Global Plasma-derived Factor VIII Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Plasma-derived Factor VIII Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Plasma-derived Factor VIII Sales 2019-2024 (K Units)
Figure 26. Americas Plasma-derived Factor VIII Revenue 2019-2024 ($ Millions)
Figure 27. APAC Plasma-derived Factor VIII Sales 2019-2024 (K Units)
Figure 28. APAC Plasma-derived Factor VIII Revenue 2019-2024 ($ Millions)
Figure 29. Europe Plasma-derived Factor VIII Sales 2019-2024 (K Units)
Figure 30. Europe Plasma-derived Factor VIII Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Plasma-derived Factor VIII Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa Plasma-derived Factor VIII Revenue 2019-2024 ($ Millions)
Figure 33. Americas Plasma-derived Factor VIII Sales Market Share by Country in 2023
Figure 34. Americas Plasma-derived Factor VIII Revenue Market Share by Country in 2023
Figure 35. Americas Plasma-derived Factor VIII Sales Market Share by Type (2019-2024)
Figure 36. Americas Plasma-derived Factor VIII Sales Market Share by Application (2019-2024)
Figure 37. United States Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Plasma-derived Factor VIII Sales Market Share by Region in 2023
Figure 42. APAC Plasma-derived Factor VIII Revenue Market Share by Regions in 2023
Figure 43. APAC Plasma-derived Factor VIII Sales Market Share by Type (2019-2024)
Figure 44. APAC Plasma-derived Factor VIII Sales Market Share by Application (2019-2024)
Figure 45. China Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Plasma-derived Factor VIII Sales Market Share by Country in 2023
Figure 53. Europe Plasma-derived Factor VIII Revenue Market Share by Country in 2023
Figure 54. Europe Plasma-derived Factor VIII Sales Market Share by Type (2019-2024)
Figure 55. Europe Plasma-derived Factor VIII Sales Market Share by Application (2019-2024)
Figure 56. Germany Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Plasma-derived Factor VIII Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Application (2019-2024)
Figure 65. Egypt Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Plasma-derived Factor VIII in 2023
Figure 71. Manufacturing Process Analysis of Plasma-derived Factor VIII
Figure 72. Industry Chain Structure of Plasma-derived Factor VIII
Figure 73. Channels of Distribution
Figure 74. Global Plasma-derived Factor VIII Sales Market Forecast by Region (2025-2030)
Figure 75. Global Plasma-derived Factor VIII Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Plasma-derived Factor VIII Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Plasma-derived Factor VIII Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Plasma-derived Factor VIII Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Plasma-derived Factor VIII Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Plasma-derived Factor VIII
Figure 2. Plasma-derived Factor VIII Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma-derived Factor VIII Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Plasma-derived Factor VIII Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Plasma-derived Factor VIII Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 200IU
Figure 10. Product Picture of 250IU
Figure 11. Global Plasma-derived Factor VIII Sales Market Share by Type in 2023
Figure 12. Global Plasma-derived Factor VIII Revenue Market Share by Type (2019-2024)
Figure 13. Plasma-derived Factor VIII Consumed in Hospital
Figure 14. Global Plasma-derived Factor VIII Market: Hospital (2019-2024) & (K Units)
Figure 15. Plasma-derived Factor VIII Consumed in Pharmacy
Figure 16. Global Plasma-derived Factor VIII Market: Pharmacy (2019-2024) & (K Units)
Figure 17. Global Plasma-derived Factor VIII Sales Market Share by Application (2023)
Figure 18. Global Plasma-derived Factor VIII Revenue Market Share by Application in 2023
Figure 19. Plasma-derived Factor VIII Sales Market by Company in 2023 (K Units)
Figure 20. Global Plasma-derived Factor VIII Sales Market Share by Company in 2023
Figure 21. Plasma-derived Factor VIII Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Plasma-derived Factor VIII Revenue Market Share by Company in 2023
Figure 23. Global Plasma-derived Factor VIII Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Plasma-derived Factor VIII Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Plasma-derived Factor VIII Sales 2019-2024 (K Units)
Figure 26. Americas Plasma-derived Factor VIII Revenue 2019-2024 ($ Millions)
Figure 27. APAC Plasma-derived Factor VIII Sales 2019-2024 (K Units)
Figure 28. APAC Plasma-derived Factor VIII Revenue 2019-2024 ($ Millions)
Figure 29. Europe Plasma-derived Factor VIII Sales 2019-2024 (K Units)
Figure 30. Europe Plasma-derived Factor VIII Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Plasma-derived Factor VIII Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa Plasma-derived Factor VIII Revenue 2019-2024 ($ Millions)
Figure 33. Americas Plasma-derived Factor VIII Sales Market Share by Country in 2023
Figure 34. Americas Plasma-derived Factor VIII Revenue Market Share by Country in 2023
Figure 35. Americas Plasma-derived Factor VIII Sales Market Share by Type (2019-2024)
Figure 36. Americas Plasma-derived Factor VIII Sales Market Share by Application (2019-2024)
Figure 37. United States Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Plasma-derived Factor VIII Sales Market Share by Region in 2023
Figure 42. APAC Plasma-derived Factor VIII Revenue Market Share by Regions in 2023
Figure 43. APAC Plasma-derived Factor VIII Sales Market Share by Type (2019-2024)
Figure 44. APAC Plasma-derived Factor VIII Sales Market Share by Application (2019-2024)
Figure 45. China Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Plasma-derived Factor VIII Sales Market Share by Country in 2023
Figure 53. Europe Plasma-derived Factor VIII Revenue Market Share by Country in 2023
Figure 54. Europe Plasma-derived Factor VIII Sales Market Share by Type (2019-2024)
Figure 55. Europe Plasma-derived Factor VIII Sales Market Share by Application (2019-2024)
Figure 56. Germany Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Plasma-derived Factor VIII Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Application (2019-2024)
Figure 65. Egypt Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Plasma-derived Factor VIII Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Plasma-derived Factor VIII in 2023
Figure 71. Manufacturing Process Analysis of Plasma-derived Factor VIII
Figure 72. Industry Chain Structure of Plasma-derived Factor VIII
Figure 73. Channels of Distribution
Figure 74. Global Plasma-derived Factor VIII Sales Market Forecast by Region (2025-2030)
Figure 75. Global Plasma-derived Factor VIII Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Plasma-derived Factor VIII Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Plasma-derived Factor VIII Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Plasma-derived Factor VIII Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Plasma-derived Factor VIII Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Oxiracetam Drugs Market Growth 2024-2030
US$ 3,660.00
December 2024
87 pages
Global Hip Protectors Market Growth 2025-2031
US$ 3,660.00
January 2025
133 pages
Global Intensity Modulated Radiation Therapy Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
81 pages
Global Suture Market Growth 2025-2031
US$ 3,660.00
December 2024
209 pages
Global Medical Devices Technologies Woundcare Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
125 pages
